Biographical Sketch
Samuel Borsellino, MD, is a Contract Staff Member in the Center for Regional Neurological Surgery at Cleveland Clinic’s main campus. His specialty interests include degenerative spine disease, complex spinal instrumentation, benign and malignant brain tumors, spine tumors, and general neurosurgery.
Dr. Borsellino earned his medical degree from The Ohio State University College of Medicine and Public Health in Columbus, Ohio. He completed an internship and residency in neurosurgery at the Cleveland Clinic in Cleveland, Ohio. He is certified by the American Board of Neurological Surgery and is a member of the American Association of Neurological Surgeons and Congress of Neurological Surgeons.
Dr. Borsellino has published several peer-reviewed articles, abstracts, and book chapters as well as having presented on topics related to neurosurgery.
Specialty Interests
and general neurosurgery, benign and malignant brain tumors, complex spinal instrumentation, degenerative spine disease, Spine Tumors, general neurosurgery
Industry Relationships
Cleveland Clinic physicians and scientists report if they
have any collaborations with the pharmaceutical or medical
device industries as part of the Cleveland Clinic’s
procedures. The Cleveland Clinic publicly discloses
payments to its physicians and scientists for speaking and
consulting of $5,000 or more per year, and any equity,
royalties, and fiduciary relationships in companies with
which they collaborate. In publicly disclosing this
information, the Cleveland Clinic tries to provide
information as accurately as possible about its doctors’
connections with industry and those of their immediate
family members. As of 9/30/2008,
Dr. Borsellino has reported no financial relationship with
industry that is applicable to this listing. Patients
should feel free to contact their doctor about
relationships with industry and how the relationships are
overseen by the Cleveland Clinic. To learn more about
the Cleveland Clinic’s policies on collaborations with
industry and innovation management, go to our
Integrity in Innovation page.